semaglutide and neuropathy linked to increased risk of vision loss in diabetes patients A new MHRA update on
Description
and 50.5% losing 15% or more body weight
Collagen can also play a supportive role here
One group received semaglutide, the other did not
To be included, patients had to have a confirmed clinical and laboratory diagnosis of partial LD (9), with no restriction for sex and age, and have started treatment with GLP-1RA and continued for 6 months without any additional change in medical treatment (except expected dose titration of background diabetes medications)
Therefore, it is highly advised to seek guidance from a healthcare professional who can evaluate the pros and cons of taking Ozempic
